Get 20% lifetime commission for referring investors to digrin.com
here.
Heron Therapeutics, Inc. ( HRTX) - Stock Earnings
HRTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
HRTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.0 million USD | 40.6 million USD |
| 2026Q1 | -8.1 million USD | 34.7 million USD |
| 2026Q2 | -5.5 million USD | 37.7 million USD |
| 2026Q4 Est. | — | — |
HRTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -110.6 million USD | 127.0 million USD |
| 2024 | -13.6 million USD | 144.3 million USD |
| 2025 | -20.2 million USD | 154.9 million USD |
| 2026 Est. | — | — |
HRTX
Price: $0.36
52 week price:
Earnings Per Share: -0.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4.0 million
Ebitda: -40.9 millionMarket Capitalization: 65.8 million